Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the...
Atreca, Inc., a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune...
Elligo Health Research, the largest healthcare-enabling research organization, announced that Elligo’s Founder and CEO, John Potthoff, Ph.D., transitioned his leadership to COO, Barry Simms. Potthoff...
TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits....
Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide methylome enrichment technology, announced...
